AUG 21, 2013 3:00 PM PDT

Discovery, Development, and Clinical Validation of Gene Expression Scores for Transplant Rejection and Coronary Artery Disease

Speaker

Abstract

Introduction Although the focus of the genomics community has largely been on DNA polymorphisms which affect disease risk, gene expression, especially of blood cells, has the potential to reflect genetic and environmental factors and to inform on both current and future disease status. The immune system dysregulation underlying many human diseases, including transplant rejection, and coronary artery disease (CAD), coupled with development of global blood gene expression profiling and quantitative RT-PCR, has enabled the clinical use of blood-based gene expression tests. Methods Blood samples were obtained from heart transplant or coronary disease patients and paired with results from gold standards of pathologist core-lab read endomyocardial biopsies (EMB) or quantitative coronary angiographic analysis on invasive angiograms, respectively. Discovery, development and validation steps were used to identify genes, develop algorithms, and validate algorithm performance with pre-specified statistical and clinical analysis plans. Development and validation cohorts were obtained in prospective multi-center trials. Finally, the performance and impact of these tests on usual care was assessed in observational or interventional studies. Results For heart transplant rejection largely independent cohorts were used to discover and develop an 11 gene algorithm to discriminate high-grade rejection from quiescence. In a set of independent patient blood samples the ROC curve AUC was 0.72; subsequent comparison of this algorithm with EMB in a prospective interventional trial met the primary endpoint of non-inferiority with a significant reduction in EMB. For CAD diagnosis, after gene discovery by microarrays, independent cohorts from a multi-center angiographic study were used to develop and validate a 23-gene whole blood RT-PCR based algorithm to discriminate obstructive CAD, with a second validation study assessing performance in patients referred for myocardial perfusion imaging. ROC AUC in these two validation studies were 0.70 and 0.79, respectively. Conclusions Blood-based gene expression tests have been developed and are being using clinically.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
AUG 21, 2013 3:00 PM PDT

Discovery, Development, and Clinical Validation of Gene Expression Scores for Transplant Rejection and Coronary Artery Disease



Show Resources
Loading Comments...
Show Resources